Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:March 15, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:March 15, 2024Recruiting
Condition(s):Neurodegenerative Diseases; Parkinson DiseaseLast Updated:December 7, 2023Recruiting
Condition(s):Multiple System AtrophyLast Updated:December 7, 2023Recruiting
Condition(s):Diabetes Mellitus Foot UlcerLast Updated:November 3, 2022Not yet recruiting
Condition(s):Cognitive DysfunctionLast Updated:March 24, 2023Recruiting
Condition(s):Multiple Sclerosis; Cognitive Dysfunction; Memory DisordersLast Updated:February 15, 2024Recruiting
Condition(s):Brain TumorLast Updated:May 22, 2023Recruiting
Condition(s):Salpingectomy; Colorectal SurgeryLast Updated:February 22, 2024Recruiting
Condition(s):HIV/AIDSLast Updated:April 27, 2022Recruiting
Condition(s):Male ContraceptionLast Updated:February 13, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.